ERFSF Quote, Financials, Valuation and Earnings

Auna SA has a net margin of -- compared to Eurofins Scientific SE's net margin of 2.26%. Eurofins Scientific SE's return on equity of 7.71% beat Auna SA's return on equity of 6.56%.

Eurofins Scientific SE has a consensus price target of --, signalling downside risk potential of --. On the other hand Auna SA has an analysts' consensus of $13.35 which suggests that it could grow by 86.19%. Given that Auna SA has higher upside potential than Eurofins Scientific SE, analysts believe Auna SA is more attractive than Eurofins Scientific SE.

Eurofins Scientific SE has a beta of 0.731, which suggesting that the stock is 26.881% less volatile than S&P 500. In comparison Auna SA has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Eurofins Scientific SE has a quarterly dividend of $0.54 per share corresponding to a yield of 0.99%. Auna SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Eurofins Scientific SE pays 23.52% of its earnings as a dividend. Auna SA pays out 0.81% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Eurofins Scientific SE quarterly revenues are --, which are smaller than Auna SA quarterly revenues of $285.9M. Eurofins Scientific SE's net income of -- is lower than Auna SA's net income of $6.5M. Notably, Eurofins Scientific SE's price-to-earnings ratio is 24.20x while Auna SA's PE ratio is 19.18x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Eurofins Scientific SE is 1.42x versus 0.45x for Auna SA. Usually stocks with elevated PS ratios are considered overvalued.

CEL-SCI has a net margin of -- compared to Eurofins Scientific SE's net margin of --. Eurofins Scientific SE's return on equity of 7.71% beat CEL-SCI's return on equity of --.

Eurofins Scientific SE has a consensus price target of --, signalling downside risk potential of --. On the other hand CEL-SCI has an analysts' consensus of $8.00 which suggests that it could grow by 3544.65%. Given that CEL-SCI has higher upside potential than Eurofins Scientific SE, analysts believe CEL-SCI is more attractive than Eurofins Scientific SE.

Eurofins Scientific SE has a beta of 0.731, which suggesting that the stock is 26.881% less volatile than S&P 500. In comparison CEL-SCI has a beta of 0.951, suggesting its less volatile than the S&P 500 by 4.939%.

Eurofins Scientific SE has a quarterly dividend of $0.54 per share corresponding to a yield of 0.99%. CEL-SCI offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Eurofins Scientific SE pays 23.52% of its earnings as a dividend. CEL-SCI pays out -- of its earnings as a dividend. Eurofins Scientific SE's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Eurofins Scientific SE quarterly revenues are --, which are smaller than CEL-SCI quarterly revenues of --. Eurofins Scientific SE's net income of -- is lower than CEL-SCI's net income of -$7.1M. Notably, Eurofins Scientific SE's price-to-earnings ratio is 24.20x while CEL-SCI's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Eurofins Scientific SE is 1.42x versus -- for CEL-SCI. Usually stocks with elevated PS ratios are considered overvalued.

Moolec Science SA has a net margin of -- compared to Eurofins Scientific SE's net margin of -166.47%. Eurofins Scientific SE's return on equity of 7.71% beat Moolec Science SA's return on equity of -93.42%.

Eurofins Scientific SE has a consensus price target of --, signalling downside risk potential of --. On the other hand Moolec Science SA has an analysts' consensus of -- which suggests that it could grow by 435.71%. Given that Moolec Science SA has higher upside potential than Eurofins Scientific SE, analysts believe Moolec Science SA is more attractive than Eurofins Scientific SE.

Eurofins Scientific SE has a beta of 0.731, which suggesting that the stock is 26.881% less volatile than S&P 500. In comparison Moolec Science SA has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Eurofins Scientific SE has a quarterly dividend of $0.54 per share corresponding to a yield of 0.99%. Moolec Science SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Eurofins Scientific SE pays 23.52% of its earnings as a dividend. Moolec Science SA pays out -- of its earnings as a dividend. Eurofins Scientific SE's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Eurofins Scientific SE quarterly revenues are --, which are smaller than Moolec Science SA quarterly revenues of $1.5M. Eurofins Scientific SE's net income of -- is lower than Moolec Science SA's net income of -$2.5M. Notably, Eurofins Scientific SE's price-to-earnings ratio is 24.20x while Moolec Science SA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Eurofins Scientific SE is 1.42x versus 3.92x for Moolec Science SA. Usually stocks with elevated PS ratios are considered overvalued.